Stephen Kent to Liposomes
This is a "connection" page, showing publications Stephen Kent has written about Liposomes.
Connection Strength
1.251
-
Patient-Specific Nanoparticle Targeting in Human Leukemia Blood. ACS Nano. 2024 10 22; 18(42):29021-29035.
Score: 0.209
-
Blood Distribution of SARS-CoV-2 Lipid Nanoparticle mRNA Vaccine in Humans. ACS Nano. 2024 10 01; 18(39):27077-27089.
Score: 0.208
-
Anti-PEG Antibodies Boosted in Humans by SARS-CoV-2 Lipid Nanoparticle mRNA Vaccine. ACS Nano. 2022 08 23; 16(8):11769-11780.
Score: 0.178
-
Current and future nanoparticle vaccines for COVID-19. EBioMedicine. 2021 Dec; 74:103699.
Score: 0.171
-
Hemagglutinin Functionalized Liposomal Vaccines Enhance Germinal Center and Follicular Helper T Cell Immunity. Adv Healthc Mater. 2021 05; 10(10):e2002142.
Score: 0.163
-
Cellular Interactions of Liposomes and PISA Nanoparticles during Human Blood Flow in a Microvascular Network. Small. 2020 08; 16(33):e2002861.
Score: 0.155
-
Beyond PEG: Emerging Polymer Lipid Alternatives for Lipid Nanoparticle (LNP) Formulations. Adv Sci (Weinh). 2026 Sep; 13(50):e77145.
Score: 0.059
-
Influence of hydrophilic polymers on the accelerated blood clearance of mRNA lipid nanoparticles upon repeated administration. Nanoscale Horiz. 2025 Nov 17; 10(12):3396-3404.
Score: 0.056
-
Replacing poly(ethylene glycol) with RAFT lipopolymers in mRNA lipid nanoparticle systems for effective gene delivery. Int J Pharm. 2024 Nov 15; 665:124695.
Score: 0.052